Kailin Medical Mao

Dr. Kailin Medical Mao


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2025 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MHMeiling Huang
Meiling Huang
MLMing Li
Ming Li
RZRong Zhu
Rong Zhu
KMKailin Medical Mao
Kailin Medical Mao
KPKun Pan
Kun Pan
BGBingmiao Gao
Bingmiao Gao
Sea anemone venoms contain diverse toxins that have significant pharmacological potential, including anticancer, ecticidal, and immunotherapeutic properties. However, critically, the extraction methodology influences venom composition and bioactivity. This study characterized venom from Stichodactyla haddoni obtained via homogenization, electrical stimulation, and milking. Extraction yields varied significantly between methods: the homogenization, electrical stimulation, and milking of healthy sea anemones yielded crude venoms at rates of 17.8%, 3.4%, and 1.5%, respectively. SDS-PAGE revealed distinct protein banding patterns and concentrations, while RP-HPLC demonstrated method-dependent compositional differences. Comprehensive proteomic profiling identified 2370 proteins, encompassing both unique and shared components across extraction techniques. Label-free quantitative analysis confirmed significant variations in protein abundance that was attributable to the extraction method. Cytotoxicity assays against cancer cell lines revealed concentration-dependent inhibition, with milking-derived venom exhibiting the highest potency. Insecticidal activity against Tenebrio molitor was also method-dependent, with milking venom inducing the highest mortality rate. These findings elucidate the profound impact of extraction methodology on the protein composition and functional activities of S. haddoni venom, providing crucial insights for its optimized exploitation in pharmacological development.

26 February 2026 in Marine Drugs
Verified
Journal Article
Open access
PDF file
LLLimin Lin
Limin Lin
MHMeiling Huang
Meiling Huang
WYWanting Yang
Wanting Yang
ZHZiqiang Hua
Ziqiang Hua
ZCZhen Chen
Zhen Chen
BGBingmiao Gao
Bingmiao Gao
Glioblastoma is a highly invasive primary brain tumor with a poor prognosis, highlighting the need for new therapeutic strategies. Toxins derived from Macrodactyla doreensis have attracted attention for their potential anticancer activity. This study evaluated the anticancer and cytotoxic effects of M. doreensis crude venom on two commonly used glioblastoma cell lines (U251 and LN229), which mirror the phenotype of primary tumors. Cell viability and proliferation were assessed using the CCK-8 assay and colony formation assay, while cell migration and invasion capabilities were detected via wound healing assay and Transwell assay. Annexin V/PI staining and PI-based cell cycle analysis indicated that the crude venom significantly induced cell apoptosis and caused S-phase arrest. Proteomic analysis combined with GO and KEGG enrichment analyses as well as bioinformatics approaches showed that M. doreensis crude venom inhibits glioblastoma cell proliferation by downregulating the expression of CDK2, RRM2, and CHEK1, thereby hindering cell cycle progression and regulating the p53 signaling pathway. Notably, the downregulation of these key glioblastoma-related target genes was validated by qPCR. In addition, network pharmacology analysis indicated that several peptide families present in the sea anemone crude venom, including ShK peptides, inhibitor cystine knot (ICK) peptides, and EGF-like peptides, exhibit notable antitumor potential. Combined with AlphaFold2-based structural modeling and molecular docking, these analyses further elucidated the potential molecular mechanisms underlying their interactions with key targets, such as MD-381 with RRM2, MD-322 with CDK2, and MD-429 with CHEK1. Collectively, these findings highlight the therapeutic potential of M. doreensis crude venom and lay a foundation for the subsequent isolation of novel peptides and their further development in glioblastoma treatment.

25 February 2025 in Marine Drugs
Verified
Journal Article
Open access
PDF file
SSShibo Sun
Shibo Sun
YLYanling Liao
Yanling Liao
JFJinxing Fu
Jinxing Fu
YLYanxia Liang
Yanxia Liang
YCYurong Chen
Yurong Chen
BGBingmiao Gao
Bingmiao Gao
The South China Sea is rich in cone snail resources, known for producing conotoxins with diverse biological activities such as analgesic, anticancer, and insecticidal effects. In this study, five vermivorous cone snail samples were collected from the South China Sea and their crude venom was extracted to investigate the variations in venom components and activities, aiming to identify highly active samples for further research. Cluster analysis using reverse-phase high-performance liquid chromatography (RP-HPLC) fingerprints and mitochondrial cytochrome c oxidase I (COI) gene sequences revealed that the diversity of venom components across different conotoxin species is genetically correlated. Activity assays demonstrated that all five cone snail venoms exhibited lethal effects on insects and zebrafish. Notably, the crude venom of Conus quercinus showed the highest insecticidal activity with an LD50 of 0.6 μg/mg, while C. tessellatus venom exhibited the most potent zebrafish lethality with an LD50 of 0.2 μg/mg. Furthermore, the crude venom from four cone snail species demonstrated toxicity against ovarian cancer cells, and only C. caracteristicu venom displayed significant analgesic activity. This study systematically identifies cone snail samples with promising insecticidal, anticancer, and analgesic properties, paving the way for the development and utilization of cone snail resources from the South China Sea and offering a novel approach for advancing marine peptide drug research.